GLADEL - Grupo Latino Americano De Estudio de Lupus

Highlighted Contents

New Publication!

New Publication!

Launching the GLADEL 2.0 Study Group.

Learn more
BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS

BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOSUS

A novel study launched by the nextgen of investigators.

Learn more
Education for physicians

Education for physicians

A new educational program about lupus

Learn more
Let's talk about Lupus

Let's talk about Lupus

Topics and frequently asked questions selected by patients.

Learn more

GLADEL, a Latin American initiative

GLADEL is an international group formed by experts in the field of SLE, including more than 50 rheumatology research centres located in main cities from more than 12 Latin American countries. The group's philosophy is inclusive, enthusiastic and looking forward to the incorporation of new centers and countries within Latin America, as new projects arise linked to the above-mentioned objectives. Decisions are always taken by consensus among equals. 

 

RECENT PUBLICATIONS

2023 Mar. 

Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohort
 

2021 Sep. 

Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review
 

2021 Jun. 

Factors associated with neuropsychiatric involvement in Latin American patients with systemic lupus erythematosus.

2021 Jan

A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group.

 

Lets talk

Sponsors

ARTHROS Web
Federico Foundation
Lupus
GLADERPO
covid